Shareholder
Hall, Render, Killian, Heath & Lyman, P.C.
Washington, District of Columbia, United States
Carolina provides strategic counsel to companies involved in the development and marketing of prescription drugs and medical devices. Having served as regulatory counsel in CDER’s Office of Regulatory Policy at the FDA, Carolina helps clients understand the inner workings of the administrative process while helping them meet their strategic goals.
A Critical Look at FDA’s Bulk Substances Interim Guidelines for Compounding Facilities
Friday, November 8, 2024
2:40 PM – 3:40 PM MT
